hATG+CsA vs hATG+CsA+Eltrombopag for SAA

PHASE3CompletedINTERVENTIONAL
Enrollment

202

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Severe Aplastic Anemia
Interventions
DRUG

hATG

DRUG

CsA

DRUG

Eltrombopag

Trial Locations (29)

Unknown

Hopital Jean Minjoz, Besançon

Hôpital Haut-Lévèque, Bordeaux

Hôpital Huriez, Lille

Centre Hospitalier Lyon-Sud, Lyon

St. Louis Hospital, Paris

Pontchaillou Hospital, Rennes

Hôpital Purpan, Toulouse

Azienda Ospedaliera Papa Giovanni XXIII, Bergamo

Istituto G. Gaslini children's Hospital, Genova

San Martino Hospital, Genova

Fondazione IRCCS ca Granda Ospedale, Milan

'Federico II' Medical School, Naples

La Sapienza University Hospital, Rome

AOU Città della Salute e della Scienza di Torino, Turin

AMC, Amsterdam

UMCG, Groningen

Leiden University Medical Center, Leiden

UMCU, Utrecht

Hospital Universitari Germans Trias I Pujol, Badalona

Institut Català d'Oncologia - Hospital Duran i Reynals, Barcelona

Donostia Hospital, Donostia / San Sebastian

Hospital La Fe, Valencia

University Hospital Basel, Basel

University Hospital Bern, Bern

University Hospital Zürich, Zurich

St. James Hospital, Leeds

King's College Hospital, London

St. Bartholomew's Hospital, London

City Hospital, Nottingham

Sponsors

Collaborators (2)

All Listed Sponsors
collaborator

Novartis

INDUSTRY

collaborator

Pfizer

INDUSTRY

lead

European Society for Blood and Marrow Transplantation

NETWORK